BANK OF AMERICA CORP /DE/ - INNATE PHARMA S A ownership

INNATE PHARMA S A's ticker is IPHA and the CUSIP is 45781K204. A total of 14 filers reported holding INNATE PHARMA S A in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of INNATE PHARMA S A
ValueSharesWeighting
Q1 2023$133,235
-77.1%
46,749
-70.0%
0.00%
Q4 2022$581,101
+76.1%
155,791
-5.5%
0.00%
Q3 2022$330,000
-30.2%
164,778
-6.0%
0.00%
Q2 2022$473,000
-19.7%
175,229
+0.0%
0.00%
Q1 2022$589,000
-47.7%
175,184
-29.1%
0.00%
Q4 2021$1,127,000
+4.9%
247,051
+41.9%
0.00%
Q3 2021$1,074,000174,1000.00%
Other shareholders
INNATE PHARMA S A shareholders Q2 2022
NameSharesValueWeighting ↓
BANK OF AMERICA CORP /DE/ 46,749$133,2350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MILLENNIUM MANAGEMENT LLC 61,899$1760.00%
MORGAN STANLEY 48,722$138,8580.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 13,315$37,8150.00%
Steward Partners Investment Advisory, LLC 500$1,4250.00%
Optiver Holding B.V. 224,097$636,4350.00%
BARCLAYS PLC 412$10.00%
ROYAL BANK OF CANADA 124$00.00%
UBS Group AG 1,259$3,5880.00%
View complete list of INNATE PHARMA S A shareholders